Analysts Set Avalo Therapeutics, Inc. (NASDAQ:AVTX) Target Price at $33.00
Avalo Therapeutics, Inc. (NASDAQ:AVTX – Get Free Report) has received a consensus rating of “Moderate Buy” from the seven ratings firms that are covering the firm, Marketbeat.com reports. One equities research analyst has rated the stock with a hold rating and six have assigned a buy rating to the company. The average twelve-month price target […]
Avalo Therapeutics, Inc. (NASDAQ:AVTX – Get Free Report) has received a consensus rating of “Moderate Buy” from the seven ratings firms that are covering the firm, Marketbeat.com reports. One equities research analyst has rated the stock with a hold rating and six have assigned a buy rating to the company. The average twelve-month price target […]
